Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
NOT YET RECRUITING
NCT06880562
NA

The RESPLASH Study

Sponsor: Tulane University

View on ClinicalTrials.gov

Summary

To assess the safety and effectiveness of renal artery denervation with subsequent splanchnic nerves denervation via catheter-based radiofrequency ablation in improving blood pressure and glycemic control in patients with resistant hypertension and type 2 diabetes.

Official title: Renal and Splanchnic Sympathetic Denervation as an Alternative Therapy for Resistant Hypertension and Type 2 Diabetes (RESPLASH Study)

Key Details

Gender

All

Age Range

18 Years - 75 Years

Study Type

INTERVENTIONAL

Enrollment

20

Start Date

2026-06

Completion Date

2027-06

Last Updated

2026-03-03

Healthy Volunteers

No

Interventions

DEVICE

Splanchnic Nerve Denervation

Catheter-based endovascular denervation (CDN) of renal arteries and splanchnic nerves (celiac + SMA) using radiofrequency ablation

DEVICE

Renal Denervation Only

Catheter-based endovascular denervation (CDN) of renal arteries only, without splanchnic nerve denervation

Locations (1)

East Jefferson General Hospital

New Orleans, Louisiana, United States